These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 15767349

  • 1. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening.
    Bray F, Loos AH, McCarron P, Weiderpass E, Arbyn M, Møller H, Hakama M, Parkin DM.
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):677-86. PubMed ID: 15767349
    [Abstract] [Full Text] [Related]

  • 2. Incidence trends of adenocarcinoma of the cervix in 13 European countries.
    Bray F, Carstensen B, Møller H, Zappa M, Zakelj MP, Lawrence G, Hakama M, Weiderpass E.
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2191-9. PubMed ID: 16172231
    [Abstract] [Full Text] [Related]

  • 3. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995.
    Sigurdsson K.
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):478-85. PubMed ID: 10376856
    [Abstract] [Full Text] [Related]

  • 4. Trends in cancer of the cervix uteri in Sweden following cytological screening.
    Bergström R, Sparén P, Adami HO.
    Br J Cancer; 1999 Sep; 81(1):159-66. PubMed ID: 10487628
    [Abstract] [Full Text] [Related]

  • 5. Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors.
    Vaccarella S, Lortet-Tieulent J, Plummer M, Franceschi S, Bray F.
    Eur J Cancer; 2013 Oct; 49(15):3262-73. PubMed ID: 23751569
    [Abstract] [Full Text] [Related]

  • 6. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
    Gunnell AS, Ylitalo N, Sandin S, Sparén P, Adami HO, Ripatti S.
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
    [Abstract] [Full Text] [Related]

  • 7. Cervical cancer.
    Beral V, Hermon C, Muñoz N, Devesa SS.
    Cancer Surv; 1994 Dec; 19-20():265-85. PubMed ID: 7534630
    [Abstract] [Full Text] [Related]

  • 8. Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention.
    Bray F, Dos Santos Silva I, Moller H, Weiderpass E.
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1132-42. PubMed ID: 15894663
    [Abstract] [Full Text] [Related]

  • 9. The changing pattern of cervical cancer in Northern Ireland 1965-1989.
    Robertson JH, Woodend B.
    Ulster Med J; 1992 Apr; 61(1):19-23. PubMed ID: 1621297
    [Abstract] [Full Text] [Related]

  • 10. Epidemiology of cancer of the cervix: global and national perspective.
    Shanta V, Krishnamurthi S, Gajalakshmi CK, Swaminathan R, Ravichandran K.
    J Indian Med Assoc; 2000 Feb; 98(2):49-52. PubMed ID: 11016150
    [Abstract] [Full Text] [Related]

  • 11. Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries.
    Bray F, Richiardi L, Ekbom A, Forman D, Pukkala E, Cuninkova M, Møller H.
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):652-8. PubMed ID: 16614105
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A model of the differentiation and relative incidence of glandular versus squamous cell neoplasia of the uterine cervix: connection between incidence and etiology.
    Leppäluoto PA.
    Acta Obstet Gynecol Scand; 2008 Apr; 87(8):800-3. PubMed ID: 18704774
    [Abstract] [Full Text] [Related]

  • 15. Incidence of cervical carcinoma in a high-risk, non-screened area results of a retrospective analysis on the Dutch Caribbean Antilles from 1983 to 1998.
    Bax A, Voigt RR, Coronel CC, Putter H, de Bie Leuving Tjeenk RM, van Marwijk HW.
    West Indian Med J; 2004 Jun; 53(3):150-4. PubMed ID: 15352742
    [Abstract] [Full Text] [Related]

  • 16. Reduction in the cumulative incidence rate of cervical cancer by one life time selective screening.
    Juneja A, Murthy NS, Tuteja RK, Sardana S, Das DK.
    Neoplasma; 1997 Jun; 44(4):272-4. PubMed ID: 9473783
    [Abstract] [Full Text] [Related]

  • 17. Epidemiology of cervical cancer in Taiwan.
    Wang PD, Lin RS.
    Gynecol Oncol; 1996 Sep; 62(3):344-52. PubMed ID: 8812531
    [Abstract] [Full Text] [Related]

  • 18. Trends in cervical cancer survival in Europe, 1983-1994: a population-based study.
    Bielska-Lasota M, Inghelmann R, van de Poll-Franse L, Capocaccia R, EUROCARE Working Group.
    Gynecol Oncol; 2007 Jun; 105(3):609-19. PubMed ID: 17399766
    [Abstract] [Full Text] [Related]

  • 19. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri.
    Nieminen P, Kallio M, Hakama M.
    Obstet Gynecol; 1995 Jun; 85(6):1017-21. PubMed ID: 7770247
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.